Pierzchała W, Ograbek M
Katedry i Kliniki Pneumonologii Slaskiej Akademii Medycznej, Katowicach.
Wiad Lek. 1998;51(3-4):166-72.
The group of 30 patients with OSA and diabetes type I or II has been examined. After the first test with MESAM 4, 5 patients with considerable nocturnal desaturation and heart rate disorders during sleep have been found. All diabetes type II. Two polisomnographic studies (the first diagnostic polisomnography and the second study for the settlement of treatment with CPAP) have been performed in the patients. After 6 months of applying CPAP all the patients have been examined again. The apnoea index was decreased (from 87.5 to 11.2) and a better control of both systemic arterial pressure and glycaemia, saturation > 80% has been obtained.
对30例阻塞性睡眠呼吸暂停（OSA）合并I型或II型糖尿病的患者进行了检查。在首次使用MESAM 4进行测试后，发现5例患者在睡眠期间存在明显的夜间血氧饱和度降低和心率紊乱。所有患者均为II型糖尿病。对这些患者进行了两项多导睡眠图研究（首次诊断性多导睡眠图和第二项用于确定持续气道正压通气（CPAP）治疗方案的研究）。在应用CPAP 6个月后，对所有患者再次进行了检查。呼吸暂停指数降低（从87.5降至11.2），并且在全身动脉压和血糖控制方面取得了更好的效果，血氧饱和度>80%。
